Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
0.5901
+0.0400 (7.27%)
At close: Mar 31, 2026, 4:00 PM EDT
0.5800
-0.0101 (-1.71%)
After-hours: Mar 31, 2026, 7:14 PM EDT

Basel Medical Group Cash Flow Statement

Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22
Net Income
-11.052.42.132.39
Depreciation & Amortization
1.180.530.560.58
Other Adjustments
11.640.170.150.1
Change in Receivables
-8.69-0.420.540.01
Changes in Inventories
-0.30.02-0.020
Changes in Accounts Payable
4.030.39-0.220.06
Changes in Income Taxes Payable
-0.65-0.18-0.29-0.03
Changes in Other Operating Activities
-0.2-0.41-0.24-0.32
Operating Cash Flow
-4.042.512.62.79
Operating Cash Flow Growth
--3.49%-6.89%-
Capital Expenditures
-0.56-0.01-0.01-0.09
Payments for Business Acquisitions
-10.34---
Investing Cash Flow
-10.9-0.01-0.01-0.09
Long-Term Debt Issued
4--1.03
Long-Term Debt Repaid
-9.58-2.92-2.94-3.09
Net Long-Term Debt Issued (Repaid)
-5.58-2.92-2.94-2.06
Issuance of Common Stock
9.75---
Net Common Stock Issued (Repurchased)
9.75---
Other Financing Activities
12.331.160-10.86
Financing Cash Flow
16.5-1.77-2.94-12.92
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-0.46---
Net Cash Flow
1.560.73-0.35-10.22
Free Cash Flow
-4.62.52.592.7
Free Cash Flow Growth
--3.56%-4.07%-
FCF Margin
-40.64%24.89%26.74%25.37%
Free Cash Flow Per Share
-0.240.150.160.17
Levered Free Cash Flow
-12.72-0.51-1.380.53
Unlevered Free Cash Flow
-8.632.171.742.36
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q